NEW YORK, Jan. 19, 2022 /PRNewswire/ --
Brain Tumor Therapeutics Market Facts at a Glance-
NEW YORK, Jan. 19, 2022 /PRNewswire/ --
Brain Tumor Therapeutics Market Facts at a Glance-
To understand more about Market Dynamics. Download our FREE sample report
According to the recent market study by Technavio, the Brain Tumor Therapeutics Market is expected to increase by USD 1.23 billion from 2020 to 2025, at an accelerated CAGR of 9.67%. The report provides a detailed analysis of drivers & opportunities, top winning strategies, competitive scenario, future market trends, market size & estimations, and major investment pockets.
North America will register the highest growth rate of 48% among the other regions. The US and Canada are the key markets for brain tumor therapeutics.
Download FREE Sample: for more additional information about the key countries in North America
The brain tumor therapeutics market report covers the following areas:
Vendor Insights-
The Brain Tumor Therapeutics Market is fragmented, and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The key offerings of some of the vendors are mentioned below:
Amgen Inc. - The company offers brain tumor therapeutics products under the brand name of Mvasi.
Bristol-Myers Squibb Co. - The company offers Ceenu, which is an anti-cancer chemotherapy that is approved for using alone or in combination with other drugs for the treatment of recurrent brain cancer.
Eisai Co. Ltd. - The company offers brain tumor therapeutics products under the brand name of Gliadel.
Find additional highlights on the vendors and their product offerings. Download Free Sample Report
Regional Market Outlook
The brain tumor therapeutics market share growth in North America will be significant during the forecast period. The US and Canada are the key markets for brain tumor therapeutics in APAC.
North America has been recording a significant growth rate. It is expected to offer several growth opportunities to market vendors during the forecast period. Strategic alliances will drive the brain tumor therapeutics market growth in North America during the forecast period.
Download our FREE sample report for more key highlights on the regional market share of most of the above-mentioned countries.
Latest Drivers & Challenges Impacting the Market-
The increasing prevalence of brain cancer is driving the growth of the brain tumor therapeutics market growth. However, factors such as high treatment costs may challenge the growth of the market.
Find additional information about various other market Drivers & Challenges mentioned in our FREE sample report.
Didn't Find What You Were Looking For? Customize Report-
Don't miss out on the opportunity to speak to our analyst and know more insights about this market report. Our analysts can also help you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer USD 1,000 worth of FREE customization at the time of purchase. Speak to our Analyst now!
Brain Tumor Therapeutics Market 2021-2025: Key Highlights
Here are Some Similar Topics-
Schizophrenia Drugs Market by Drug Class and Geography - Forecast and Analysis 2021-2025
Brain Tumor Therapeutics Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.67% |
Market growth 2021-2025 |
USD 1.23 billion |
Market structure |
Fragmented |
YoY growth (%) |
9.10 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 48% |
Key consumer countries |
US, Germany, UK, Canada, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Companies profiled |
Amgen Inc., Bristol-Myers Squibb Co., Eisai Co. Ltd., Emcure Pharmaceuticals Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Merck and Co. Inc., NextSource Pharmaceuticals LLC, Novartis AG, and Y-mAbs Therapeutics Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article